Explore the words cloud of the Implant maintenance project. It provides you a very rough idea of what is the project "Implant maintenance" about.
The following table provides information about the project.
Coordinator |
LABRIDA AS
Organization address contact info |
Coordinator Country | Norway [NO] |
Project website | http://www.labrida.com |
Total cost | 71˙429 € |
EC max contribution | 50˙000 € (70%) |
Programme |
1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies) |
Code Call | H2020-SMEINST-1-2014 |
Funding Scheme | SME-1 |
Starting year | 2015 |
Duration (year-month-day) | from 2015-06-01 to 2015-11-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | LABRIDA AS | NO (OSLO) | coordinator | 50˙000.00 |
Peri-implant disease (Mucositis and peri-implantitis) is a major and growing clinical problem in odontology, affecting 20-40 mill. patients in Europe, and the double worldwide. Labrida has developed, clinically documented and CE marked a novel, patented (pending) maintenance device for non-surgical management of peri-implant disease. It is a revision brush (“BioClean”), with bioresorbable bristles made of mono-filament chitosan fibres (Patented by Medovent, DE). It offers safer, more effective, less painful and faster treatment of peri-implant disease, where currently the clinical community is in search for adequate solutions. The instrument addresses a market in the range of Euro 1-2 billion annual turnover. The device is in small scale production and sold commercially in Scandinavia (TRL 7), with most promising market response. To meet the market opportunity, we will develop up-scaled production processes of advanced chitosan fibres, which is critical to increase overall production requirements. In addition, we have started development with clinical pilot testing of the next generation product, comprising chitosan bristles combined with antibiotics, with interesting clinical results. This may open a broader application field for deployment of these combinations of materials technologies, both within odontology and wider in medicine. The overall planned project (Phase 2) comprises both industrial development of scaled up production technologies for the chitosan fibres of the currently marketed product , as well as development of the next generation product, combining advanced chitosan technologies with bioactive material, e.g. in nanospheres. In phase 1, we intend to refine the development plan of these product(s) for phase 2, including assessing more in detail the business case, and additional application areas, of the 2nd generation product.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMPLANT MAINTENANCE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IMPLANT MAINTENANCE" are provided by the European Opendata Portal: CORDIS opendata.
Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.
Read MoreCOHESIVE BANDAGES BASED ON NATURAL FIBRES, WITH ANTIMICROBIAL AND HYDROPHOBIC PROPERTIES BY MLSE TECHNOLOGY
Read More